Last update 08 May 2025

MT007-LRPIV

Overview

Basic Info

Drug Type
Recombinant protein
Synonyms
recombinant LRP fragments (Socratech)
Target
APP x LRP1
Action
inhibitors, modulators
Mechanism
APP inhibitors(Beta amyloid A4 protein inhibitors), LRP1 modulators(LDL receptor related protein 1 modulators)
Therapeutic Areas
Nervous System Diseases
Active Indication-
Inactive Indication
Alzheimer Disease
Originator Organization
Socratech LLC
Active Organization-
Inactive Organization
Socratech LLCZZ Biotech LLCZZ Biotech LLC
License Organization-
Drug Highest PhaseDiscontinuedDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with MT007-LRPIV
Login to view more data
100 Translational Medicine associated with MT007-LRPIV
Login to view more data
100 Patents (Medical) associated with MT007-LRPIV
Login to view more data
100 Deals associated with MT007-LRPIV
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alzheimer DiseaseDiscovery
United States
ZZ Biotech LLCZZ Biotech LLC
-
Alzheimer DiseaseDiscovery
United States
Socratech LLC
-
Alzheimer DiseaseDiscovery
United States
ZZ Biotech LLCZZ Biotech LLC
-
Alzheimer DiseaseDiscovery
United States
Socratech LLC
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free